Wells Fargo & Company Cassava Sciences Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Cassava Sciences Inc stock. As of the latest transaction made, Wells Fargo & Company holds 17,550 shares of SAVA stock, worth $445,945. This represents 0.0% of its overall portfolio holdings.

Number of Shares

17,550

Previous 16,354 7.31%

Holding current value

$445,945

Previous $331,000 34.74%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$12.35 - $26.11 $14,770 - $31,227	1,196 Added 7.31%	17,550 $216,000
Q1 2024 May 10, 2024	BUY	$18.44 - $26.41 $40,088 - $57,415	2,174 Added 15.33%	16,354 $331,000
Q4 2023 Feb 09, 2024	BUY	$12.64 - $30.11 $20,716 - $49,350	1,639 Added 13.07%	14,180 $319,000
Q3 2023 Nov 13, 2023	SELL	$16.64 - $25.32 $127,112 - $193,419	-7,639 Reduced 37.85%	12,541 $208,000
Q2 2023 Aug 15, 2023	BUY	$21.59 - $27.88 $207,004 - $267,313	9,588 Added 90.52%	20,180 $494,000
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $172,853 - $268,489	7,368 Added 228.54%	10,592 $255,000
Q4 2022 Feb 13, 2023	SELL	$27.82 - $44.16 $9,848 - $15,632	-354 Reduced 9.89%	3,224 $95,000
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $21,016 - $65,714	1,287 Added 56.18%	3,578 $150,000
Q2 2022 Aug 12, 2022	SELL	$17.22 - $38.47 $134,023 - $299,412	-7,783 Reduced 77.26%	2,291 $64,000
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $985,367 - $1.6 Million	-30,226 Reduced 75.0%	10,074 $374,000
Q4 2021 Feb 14, 2022	BUY	$36.77 - $90.91 $545,041 - $1.35 Million	14,823 Added 58.18%	40,300 $1.76 Million
Q3 2021 Nov 15, 2021	BUY	$41.79 - $135.3 $434,448 - $1.41 Million	10,396 Added 68.93%	25,477 $1.58 Million
Q2 2021 Aug 16, 2021	SELL	$32.15 - $89.72 $603,873 - $1.69 Million	-18,783 Reduced 55.47%	15,081 $1.29 Million
Q1 2021 May 13, 2021	SELL	$7.09 - $87.95 $926,712 - $11.5 Million	-130,707 Reduced 79.42%	33,864 $1.52 Million
Q4 2020 Feb 09, 2021	BUY	$6.79 - $12.25 $728,471 - $1.31 Million	107,286 Added 187.28%	164,571 $1.12 Million
Q3 2020 Nov 05, 2020	BUY	$2.86 - $11.51 $43,125 - $173,559	15,079 Added 35.73%	57,285 $660,000
Q2 2020 Aug 13, 2020	BUY	$2.04 - $9.64 $80,394 - $379,902	39,409 Added 1408.97%	42,206 $130,000
Q1 2020 May 14, 2020	BUY	$3.26 - $9.65 $9,118 - $26,991	2,797 New	2,797 $12,000

Others Institutions Holding SAVA

# of Institutions

186

Shares Held

13.3M

Call Options Held

1.38M

Put Options Held

2.04M

View Full List

About CASSAVA SCIENCES INC

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $1.02B
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

More about SAVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cassava Sciences Inc Transaction History